← 홈

ADC

227개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 227개
ADCBiologicstaleShanghai Fudan-Zhangjiang Bio-P…Phase 1

FDA018-ADC (FDA018-ADC)

Advanced/ Metastatic Solid Tumors · Triple Negative Breast Cancer

#TripleNegativeBreastCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
ADCBiologicstaleGeneQuantum Healthcare (Suzhou)…Phase 1

GQ1001 (GQ1001)

HER2-positive Breast Cancer; HER2-positive Biliary Tract Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 ACTIVE
ADCBiologicstaleGeneQuantum Healthcare (Suzhou)…-mediatedPhase 3

GQ1005 (GQ1005)

HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+4
임상시험 2상태 RECRUITING
ADCBiologicstaleShanghai Henlius BiotechPhase 3

HLX87 + HLX22 (HLX87 + HLX22)

HER2 + Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleSilverback TherapeuticsPhase 2

SBT6050 (SBT6050)

HER2-positive Breast Cancer; HER2-positive Gastric Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 1%임상시험 2상태 ACTIVE
ADCBiologicstaleJiangsu HengRui Medicine Co., L…Phase 2

SHR-1316 (SHR-1316)

Breast Neoplasm; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
ADCBiologicstaleMarengo Therapeutics, Inc.Phase 2

STAR0602 (STAR0602)

Triple Negative Locally Advanced Non-resectable Breast Cancer; HR+, HER2-, Advanced Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
임상시험 2상태 RECRUITING
ADCBiologicstaleCSPC Megalith Biopharmaceutical…Phase 2

SYS6023 (SYS6023)

Advanced Breast Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleFudan UniversityPhase 2

TQB2102 with TQB2868 (TQB2102 with TQB2868)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 RECRUITING
ADCBiologicstaleFudan UniversityPhase 2

A1: SHR-A1811 (A1: SHR-A1811)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleJiangsu HengruiPhase 2

A2: SHR-A1811 with Camrelizumab with famitinib (A2: SHR-A1811 with Camrelizumab with famitinib)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleAdcentrx TherapeuticsPhase 1

ADRX-0706 (ADRX-0706)

Solid Tumors; Triple Negative Breast Cancer (TNBC) · Solid Tumors

#SolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleAlteogen, Inc.Phase 1

HM2-MMAE (ALT-P7, ALT-P7 (HM2-MMAE))

HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
ADCBiologicstaleRemeGen Co., Ltd.Govitecan in Untreated, Adv…Phase 2

Albumin-bound Paclitaxone (Albumin-bound Paclitaxone)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleFudan UniversityPhase 2

B2: TROP2 ADC with Camrelizumab (B2: TROP2 ADC with Camrelizumab)

Triple-negative Breast Cancer · TROP2

#TROP2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleEisai Inc.Phase 2

BB-1701 (BB-1701)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 ACTIVE
ADCBiologicstaleBioNTech SEPhase 2

BNT323 (BNT323)

Locally Advanced Breast Cancer; Unresectable Breast Carcinoma · Locally Advanced Breast Cancer

#LocallyAdvancedBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleFudan UniversityPhase 2

Benmelstobart (Benmelstobart)

Breast Neoplasm; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleFudan UniversityPhase 2

C1: SHR-A1811 (C1: SHR-A1811)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleFudan UniversityPhase 2

C2: SHR-A1811 with BP102 (C2: SHR-A1811 with BP102)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING

9 / 12 페이지

← 이전다음 →